Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 22;46(1):1-9.
doi: 10.1017/ice.2024.161. Online ahead of print.

Comparing the effectiveness of universal admission testing and risk-based testing at emergency admission for preventing nosocomial COVID-19: a multicenter retrospective cohort study in Japan

Affiliations

Comparing the effectiveness of universal admission testing and risk-based testing at emergency admission for preventing nosocomial COVID-19: a multicenter retrospective cohort study in Japan

Kenta Iijima et al. Infect Control Hosp Epidemiol. .

Abstract

Objective: To compare the effectiveness of universal admission testing (UAT) and risk-based testing (RBT) in preventing nosocomial coronavirus disease 2019 (COVID-19) after the implementation of strict infection control measures.

Design: Retrospective multicenter cohort study.

Setting: Five community hospitals in Japan.

Patients: 14,028 adult patients admitted emergently from June 1, 2022, to January 31, 2023.

Methods: We calculated crude incidence density rates of community-acquired COVID-19 (positive test ≤4 days postadmission), hospital-acquired COVID-19 (positive test ≥8 days postadmission), total postadmission COVID-19 (all cases of positive test postadmission), and primary cases (sporadic and index cases). A generalized estimating equation model was used to adjust for local incidence (new COVID-19 patients per 100,000 population), single-bed room proportion, and admission proportion of patients older than 65 years.

Results: The weekly local incidence in the study areas was less than 1,800 per 100,000 population (1.8%). Two hospitals implemented RBT and 3 implemented UAT. The median admission testing rate was higher in the UAT group than in the RBT group (95% vs 55%; difference 45.2%, 95% CI, 40.3%-48.8%). Crude and adjusted analyses revealed no significant associations between incidence density rates (IRR; >1 indicates higher incidence with UAT) and admission strategies for any of the outcomes: community-acquired cases (adjusted IRR = 1.23; 95% CI, 0.46-3.31), hospital-acquired cases (1.46; 0.80-2.66), total postadmission COVID-19 (1.22; 0.79-1.87), and primary cases (0.81; 0.59-1.12).

Conclusions: Compared with risk-based testing, universal admission testing may have limited additional benefits in preventing nosocomial COVID-19 transmission during a period of low-moderate local incidence.

PubMed Disclaimer

Conflict of interest statement

All authors report no conflicts of interest relevant to this article.

Figures

Figure 1.
Figure 1.
Flow diagram of patient enrollment in the study.
Figure 2.
Figure 2.
Crude weekly mean incidence density rate (solid line), admission testing rate (dashed line), and local incidence rate in Hyogo Prefecture (bar graph). Universal admission testing group (filled circle, blue) and risk-based testing group (filled triangle, orange). The vertical axis shows (left-most) the incidence density rate per 1,000 at-risk patient days, (left-most) Hyogo Prefecture’s incidence rate (%), and (right-most) the testing rate (%).

Similar articles

References

    1. Evans S, Naylor NR, Fowler T, Hopkins S, Robotham J. The effectiveness and efficiency of asymptomatic SARS-CoV-2 testing strategies for patient and healthcare workers within acute NHS hospitals during an omicron-like period. BMC Infect Dis 2024;24:64. - PMC - PubMed
    1. Dave N, Sjoholm D, Hedberg P, et al. Nosocomial SARS-CoV-2 infections and mortality during unique COVID-19 epidemic waves. JAMA Netw Open 2023;6:e2341936. - PMC - PubMed
    1. Klompas M, Baker MA, Rhee C. Is nosocomial SARS-CoV-2 still worth preventing? JAMA Netw Open 2023;6:e2344704. - PubMed
    1. Williams VR, Chan CK, Chan AK, Kozak R, Leis JA. Impact of universal admission testing for severe acute respiratory coronavirus 2 (SARS-CoV-2) in era of the omicron variant. Infect Control Hosp Epidemiol 2023;44:102–105. - PubMed
    1. Pak TR, Rhee C, Wang R, Klompas M. Discontinuation of universal admission testing for SARS-CoV-2 and hospital-onset COVID-19 infections in England and Scotland. JAMA Intern Med 2023;183:877–880. - PMC - PubMed